Venrock Healthcare Capital Partners III, L.P.'s Net Worth

Estimate Recalculated Nov 1, 2024 02:24PM EST

Who is Venrock Healthcare Capital Partners III, L.P.

Venrock Healthcare Capital Partners III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., CONSTELLATION PHARMACEUTICALS INC, Altimmune, Inc., Unum Therapeutics Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Bellerophon Therapeutics, Inc..

SEC CIK

Venrock Healthcare Capital Partners III, L.P.'s CIK is 0001738048

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC

Investor

Updated Dec 16, 2019


Form 4	11.06%	400.00K	$34.50	$13.80M	Dec 16, 2019	4.02M	Purchase	—	Dec 13
Form 3	—	—	—	—	Oct 04, 2019	3.62M	—	—	—

Showing 2 results

KalVista Pharmaceuticals, Inc.

Investor

Updated Feb 22, 2024

View Quote Details


Form 4	—	655.74K	$15.25	$10.00M	Feb 22, 2024	655.74K	Purchase	—	Feb 20
Form 4	1.82%	86.05K	$14.62	$1.26M	Feb 08, 2024	4.82M	Purchase	—	Feb 06 - Feb 08
Form 4	1.89%	88.10K	$14.47	$1.27M	Feb 01, 2024	4.74M	Purchase	—	Jan 30
Form 4	2.01%	91.80K	$14.05	$1.29M	Jan 29, 2024	4.65M	Purchase	—	Jan 25 - Jan 29
Form 4	2.22%	99.13K	$12.53	$1.24M	Jan 24, 2024	4.56M	Purchase	—	Jan 22 - Jan 24
Form 4	3.33%	143.60K	$12.55	$1.80M	Jan 19, 2024	4.46M	Purchase	—	Jan 17 - Jan 19
Form 4	0.61%	26.25K	$12.72	$333.78K	Jan 16, 2024	4.32M	Purchase	—	Jan 11 - Jan 16
Form 4	3.32%	137.70K	$12.54	$1.73M	Jan 10, 2024	4.29M	Purchase	—	Jan 08 - Jan 10
Form 4	1.45%	59.37K	$12.14	$720.54K	Jan 05, 2024	4.15M	Purchase	—	Jan 03 - Jan 04
Form 4	14.52%	519.02K	$12.46	$6.47M	Dec 29, 2023	4.09M	Purchase	—	Dec 27 - Dec 29
Form 3	—	—	—	—	Dec 28, 2023	3.57M	—	—	—
Form 4	-24.46%	-500.00K	$28.75	-$14.37M	Mar 20, 2019	1.54M	Sale	—	Mar 18
Form 3	—	—	—	—	Sep 10, 2018	2.04M	—	—	—

Showing 13 results

Altimmune, Inc.

Investor

Updated Mar 01, 2021

View Quote Details


Form 4	—	—	—	—	Mar 01, 2021	4.50M	Acq/Dis	—	Feb 25
Form 4	50.00%	1.50M	$7.54	$11.31M	Jun 15, 2020	4.50M	Purchase	—	Jun 15
Form 4	76.85%	1.30M	$8.74	$11.40M	May 28, 2020	3.00M	Purchase	—	May 26 - May 28
Form 3	—	—	—	—	May 28, 2020	1.70M	—	—	—

Showing 4 results

Unum Therapeutics Inc.

Investor

Updated Aug 18, 2020

View Quote Details


Form 4	11.55%	451.00K	$2.52	$1.14M	Aug 18, 2020	4.36M	Purchase	—	Aug 14 - Aug 18
Form 3	—	—	—	—	Aug 18, 2020	3.90M	—	—	—

Showing 2 results

Tricida, Inc.

Investor

Updated Oct 26, 2022


Form 4	-63.23%	-6.45M	$0.54	-$3.50M	Oct 26, 2022	3.75M	Sale	—	Oct 24 - Oct 26
Form 4	3.57%	351.87K	$10.68	$3.76M	Oct 20, 2022	10.20M	Purchase	—	Oct 18 - Oct 19
Form 4	1.81%	174.97K	$11.68	$2.04M	Oct 17, 2022	9.85M	Purchase	—	Oct 13 - Oct 17
Form 4	1.41%	134.21K	$11.91	$1.60M	Oct 11, 2022	9.68M	Purchase	—	Oct 07 - Oct 11
Form 4	2.39%	223.10K	$11.81	$2.63M	Oct 06, 2022	9.54M	Purchase	—	Oct 04
Form 4	4.92%	436.92K	$10.75	$4.70M	Oct 03, 2022	9.32M	Purchase	—	Sep 29 - Oct 03
Form 4	7.08%	587.21K	$8.90	$5.23M	Sep 28, 2022	8.88M	Purchase	—	Sep 26 - Sep 28
Form 4	9.03%	686.71K	$11.53	$7.92M	Sep 07, 2022	8.29M	Purchase	—	Sep 02 - Sep 07
Form 4	0.66%	50.00K	$12.20	$610.00K	Sep 01, 2022	7.61M	Purchase	—	Aug 30
Form 4	0.25%	18.90K	$9.21	$174.07K	Aug 02, 2022	7.56M	Purchase	—	Jul 29
Form 4	0.99%	74.20K	$9.26	$687.18K	Jul 25, 2022	7.54M	Purchase	—	Jul 21 - Jul 25
Form 4	2.05%	150.00K	$9.18	$1.38M	Jul 20, 2022	7.46M	Purchase	—	Jul 18 - Jul 20
Form 4	1.31%	94.57K	$9.88	$934.82K	Jul 14, 2022	7.31M	Purchase	—	Jul 12 - Jul 14
Form 4	1.24%	88.20K	$9.61	$847.23K	Jul 06, 2022	7.22M	Purchase	—	Jul 01 - Jul 05
Form 4	0.89%	62.87K	$9.76	$613.51K	Jun 30, 2022	7.13M	Purchase	—	Jun 28 - Jun 30
Form 4	7.48%	492.02K	$10.37	$5.10M	Jun 24, 2022	7.07M	Purchase	—	Jun 22 - Jun 24
Form 4	0.09%	5.95K	$9.69	$57.67K	Jun 21, 2022	6.58M	Purchase	—	Jun 16
Form 4	1.83%	118.05K	$8.57	$1.01M	Jun 14, 2022	6.57M	Purchase	—	Jun 10 - Jun 14
Form 4	10.03%	588.02K	$9.65	$5.67M	Jun 09, 2022	6.45M	Purchase	—	Jun 07 - Jun 09
Form 4	3.36%	190.87K	$9.16	$1.75M	Jun 06, 2022	5.87M	Purchase	—	Jun 02 - Jun 06
Form 3	—	—	—	—	Jun 06, 2022	5.67M	—	—	—

Showing 21 results

Vistagen Therapeutics, Inc.

Investor

Updated Jul 14, 2022

View Quote Details


Form 4	-0.29%	-60.00K	$0.89	-$53.40K	Jul 14, 2022	20.64M	Sale	—	Jul 12
Form 3	—	—	—	—	Jul 08, 2022	20.70M	—	—	—

Showing 2 results

Bellerophon Therapeutics, Inc.

Investor

Updated Oct 28, 2019

View Quote Details


Form 4	-14.53%	-1.09M	$0.48	-$524.96K	Oct 28, 2019	6.44M	Sale	—	Oct 24 - Oct 28
Form 4	1.93%	142.86K	$0.70	$100.00K	Mar 14, 2019	7.53M	Purchase	—	Jan 23
Form 4	2.93%	210.00K	$1.20	$252.35K	Sep 17, 2018	7.39M	Purchase	—	Sep 13 - Sep 17
Form 4	7.09%	475.00K	$1.18	$558.39K	Sep 12, 2018	7.18M	Purchase	—	Sep 10 - Sep 12
Form 4	2.45%	160.00K	$0.86	$138.16K	Sep 07, 2018	6.70M	Purchase	—	Sep 05 - Sep 07

Showing 5 results